» Articles » PMID: 18581145

Renal Function in Children with Beta-thalassemia Major and Thalassemia Intermedia

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 2008 Jun 27
PMID 18581145
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

In beta-thalassemia, profound anemia and severe hemosiderosis cause functional and physiological abnormalities in various organ systems. In recent years, there have been few published studies demonstrating proteinuria, aminoaciduria, low urine osmolality, and excess secretion of the tubular damage markers, such as urinary N-acetyl-D-glucosaminidase (U(NAG)) and beta2 microglobulin, in patients with thalassemia. The object of this study was to analyze renal tubular and glomerular function in pediatric patients with beta-thalassemia and to correlate the renal findings to iron overload. Thirty-seven patients with beta-thalassemia major and 11 with thalassemia intermedia were studied. Twelve children without iron metabolism disorders or renal diseases served as a control group. No difference in blood urea nitrogen (BUN), serum creatinine, creatinine clearance, electrolytes, fractional excretion of sodium and potassium, and tubular phosphorus reabsorption was found. Serum uric acid was equal in the two groups, but its urine excretion was significantly higher in the thalassemic group. U(NAG) and U(NAG) to creatinine ratio (U(NAG/CR)) were elevated in all patients with thalassemia compared with the control group (p < 0.001) and were directly correlated to the amount of transfused iron but not to actual ferritin level. We found that renal tubular function is impaired in children with beta- thalassemia major and intermedia. It is not known whether these functional abnormalities would have any long-term effects on the patients. Further studies are needed, and means of preventing these disturbances should be sought.

Citing Articles

Clinical features and risk factors of renal dysfunctions in thalassemic patients.

Thongsaen P, Tonsawan P, Wanitpongpun C, Lanamtieng T, Phiphitaporn P, Teawtrakul N Int Urol Nephrol. 2023; 55(7):1779-1785.

PMID: 36749473 DOI: 10.1007/s11255-023-03506-3.


Renal Function in Patients with Thalassemia Major Receiving Exjade Dispersible Tablets and a New Film-coated Tablet Formulation of Deferasirox (Nanojade).

Falahati V, Ghasemi A, Safari M, Ghaffari K, Yousefichaijan P, Zamanian M Adv Biomed Res. 2022; 11:84.

PMID: 36518868 PMC: 9744082. DOI: 10.4103/abr.abr_89_21.


Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review.

Zaky Romadhon P, Ashariati A, Bintoro S, Thaha M, Suryantoro S, Windradi C J Blood Med. 2022; 13:725-738.

PMID: 36467279 PMC: 9717586. DOI: 10.2147/JBM.S387416.


Renal function in β-thalassemia major patients treated with two different iron-chelation regimes.

Tanous O, Azulay Y, Halevy R, Dujovny T, Swartz N, Colodner R BMC Nephrol. 2021; 22(1):418.

PMID: 34930156 PMC: 8691002. DOI: 10.1186/s12882-021-02630-5.


Do We Store Packed Red Blood Cells under "Quasi-Diabetic" Conditions?.

Livshits L, Barshtein G, Arbell D, Gural A, Levin C, Guizouarn H Biomolecules. 2021; 11(7).

PMID: 34356616 PMC: 8301930. DOI: 10.3390/biom11070992.


References
1.
Lindsey W, Olin B . Deferasirox for transfusion-related iron overload: a clinical review. Clin Ther. 2007; 29(10):2154-66. DOI: 10.1016/j.clinthera.2007.10.015. View

2.
LANDING B, Gonick H, Nadorra R, Hyman C, Wells T, Mersch J . Renal lesions and clinical findings in thalassemia major and other chronic anemias with hemosiderosis. Pediatr Pathol. 1989; 9(5):479-500. DOI: 10.3109/15513818909026908. View

3.
Cianciulli P, Sollecito D, Sorrentino F, Forte L, Gilardi E, Massa A . Early detection of nephrotoxic effects in thalassemic patients receiving desferrioxamine therapy. Kidney Int. 1994; 46(2):467-70. DOI: 10.1038/ki.1994.295. View

4.
Khalifa A, Sheir S, el Magd L, el Tayeb H, el Lamie O, Khalifa A . The kidney in beta-thalassaemia major. Acta Haematol. 1985; 74(1):60. DOI: 10.1159/000206169. View

5.
Ong-Ajyooth L, Malasit P, Fucharoen S, Pootrakul P, Vasuvattakul S, Siritanaratkul N . Renal function in adult beta-thalassemia/Hb E disease. Nephron. 1998; 78(2):156-61. DOI: 10.1159/000044904. View